Vaccination is a safe, simple, and effective way of protecting a person against COVID-19. By the end of August 2021, only 24.6% of the world population has received two doses of a COVID-19 vaccine. Since the emergence of COVID-19, several COVID-19 vaccines have been developed and ...
This effect has included the adverse outcomes in patients with cancer who develop COVID-19, the impact of the COVID-19 pandemic on the delivery of cancer care, and the severe disruption to cancer research. However, patients with cancer are a heterogeneous population, and recent studies have ...
Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) recently was declared a pandemic by world health organization (WHO) Due to sudden outbreaks, currently, no completely effective vaccine or drug is clinically approved. Several therapeutic strategies ...
Additionally, Health Canada, the federal agency in charge of COVID-19 regulations, has announced that the country’s COVID vaccine requirement will also expire on September 30, 2022. Effective October 1, all travelers, regardless of citizenship, will no longer be required to: submit public healt...
current COVID-19 vaccines (see sections “Biosynthesis and key properties of the spike protein” and “Vaccine-specific differences of S-antigen structure and presentation” and Table1). Constituents in the Oxford-AstraZeneca vaccine were recently analyzed in the context of a search for potential ...
Development of Dermatomyositis after Pfizer BioNTeh COVID-19 Vaccine: A Case Report. June 14, 2023 [ MEDLINE Abstract ] Calcium Folate for Reducing the Side Effects of Low-dose Methotrexate in Rheumatoid Arthritis: A Case Report. June 12, 2023 [ MEDLINE Abstract ] A routine Over the...
More importantly, many teams worldwide have employed multiple strategies to develop vaccines against COVID-19, which need to undergo stringent clinical trials, as in the case of drugs [105]. These vaccines include nucleic acid vaccine (DNA or RNA), adenovirus vaccine, inactivated virus vaccine, ...
COVID-19. This brief review summarized what we have hitherto learned in the following areas: epidemiology, virology, and pathogenesis, diagnosis, use of artificial intelligence in assisting diagnosis, treatment, and vaccine development. As there are a number of parallel developments in each of these...
3. Immune reactions and pathogenesis of COVID-19 4. Coronavirus vaccines 5. Candidate vaccines for severe acute respiratory syndrome 6. Candidate vaccines for middle east respiratory syndrome (MERS) 7. Antibody-dependent enhancement 8. SARS-CoV-2 targets for the development of the vaccine 9. Ongo...
4 This panic and stress are further raised by conflicting information about the coronavirus, the absence of a medical cure and vaccine, electronic and print media buzz regarding the COVID-19 deaths, infection rates, overcrowded hospitals, and other negative information about the pandemic.5 Along ...